IT1168028B - Impiego di inibitori dell'aromatasi per la profilassi e la terapia della iperplasia della prostata - Google Patents
Impiego di inibitori dell'aromatasi per la profilassi e la terapia della iperplasia della prostataInfo
- Publication number
- IT1168028B IT1168028B IT24117/81A IT2411781A IT1168028B IT 1168028 B IT1168028 B IT 1168028B IT 24117/81 A IT24117/81 A IT 24117/81A IT 2411781 A IT2411781 A IT 2411781A IT 1168028 B IT1168028 B IT 1168028B
- Authority
- IT
- Italy
- Prior art keywords
- prophylaxis
- therapy
- prophyactic
- aromatase inhibitors
- aromatase
- Prior art date
Links
- 239000003886 aromatase inhibitor Substances 0.000 title abstract 4
- 229940046844 aromatase inhibitors Drugs 0.000 title abstract 2
- 238000011321 prophylaxis Methods 0.000 title abstract 2
- 238000002560 therapeutic procedure Methods 0.000 title abstract 2
- 229940122815 Aromatase inhibitor Drugs 0.000 abstract 2
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 abstract 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- BPEWUONYVDABNZ-DZBHQSCQSA-N testolactone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(OC(=O)CC4)[C@@H]4[C@@H]3CCC2=C1 BPEWUONYVDABNZ-DZBHQSCQSA-N 0.000 abstract 1
- 229960005353 testolactone Drugs 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19813121153 DE3121153A1 (de) | 1981-05-22 | 1981-05-22 | "verwendung von aromatase-hemmern zur prophylaxe und therapie der prostatahyperplasie" |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IT8124117A0 IT8124117A0 (it) | 1981-09-24 |
| IT1168028B true IT1168028B (it) | 1987-05-20 |
Family
ID=6133383
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT24117/81A IT1168028B (it) | 1981-05-22 | 1981-09-24 | Impiego di inibitori dell'aromatasi per la profilassi e la terapia della iperplasia della prostata |
Country Status (13)
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0114033B1 (de) * | 1982-12-21 | 1988-10-12 | Ciba-Geigy Ag | Substituierte Azabicycloalkane, ihre Verwendung, pharmazeutische Präparate, welche diese Verbindungen enthalten, und Verfahren zur Herstellung dieser Verbindungen |
| DE3323321A1 (de) * | 1983-06-24 | 1985-01-03 | Schering AG, 1000 Berlin und 4709 Bergkamen | Prophylaxe und therapie von koronaren herzkrankheiten durch senkung des oestrogenspiegels |
| GB8531747D0 (en) * | 1985-12-24 | 1986-02-05 | Erba Farmitalia | 10beta-alkynylestrene derivatives |
| GB8624251D0 (en) * | 1986-10-09 | 1986-11-12 | Erba Farmitalia | "1,2-beta-methylene-4-substituted androstene-3,17 dione derivatives |
| US5595985A (en) * | 1989-03-10 | 1997-01-21 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| AU643445B2 (en) * | 1989-07-07 | 1993-11-18 | Endorecherche Inc. | Combination therapy for prophylaxis and/or treatment of benign prostatic hyperplasia |
| US5227375A (en) * | 1990-02-08 | 1993-07-13 | Endorecherche, Inc. | Aromatase inhibitors |
| KR0180008B1 (ko) * | 1991-03-28 | 1999-04-01 | 야마구찌 다까시 | 신규 옥사-또는 아자스테로이드 유체 |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US6649645B1 (en) * | 1998-12-23 | 2003-11-18 | Pharmacia Corporation | Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia |
| EP1140183A1 (en) | 1998-12-23 | 2001-10-10 | G.D. Searle & Co. | Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| US6858598B1 (en) | 1998-12-23 | 2005-02-22 | G. D. Searle & Co. | Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| US7939517B2 (en) * | 2004-07-21 | 2011-05-10 | Kneller Bruce W | 1,4,6-androstatriene-3,17-dione (“ATD”) for therapeutic uses |
| EP1854465A1 (en) | 2006-05-12 | 2007-11-14 | Alexander Tobias Teichmann | Use of 4,17 beta-dihydroxyandrost-4-ene-3-one for treating cancers |
| US20080245375A1 (en) * | 2007-04-05 | 2008-10-09 | Medtronic Vascular, Inc. | Benign Prostatic Hyperplasia Treatments |
| EP2500062B1 (en) * | 2007-11-13 | 2015-08-12 | Curadis GmbH | C-19 steroids for specific therapeutic uses |
| CA2794565C (en) | 2010-04-08 | 2018-08-21 | Emory University | Substituted androst-4-ene diones |
| US20160361380A1 (en) | 2015-06-12 | 2016-12-15 | Nymox Corporation | Combination compositions for treating disorders requiring removal or destruction of unwanted cellular proliferations |
| US10183058B2 (en) | 2016-06-17 | 2019-01-22 | Nymox Corporation | Method of preventing or reducing the progression of prostate cancer |
| US10172910B2 (en) | 2016-07-28 | 2019-01-08 | Nymox Corporation | Method of preventing or reducing the incidence of acute urinary retention |
| US10532081B2 (en) | 2016-09-07 | 2020-01-14 | Nymox Corporation | Method of ameliorating or preventing the worsening or the progression of symptoms of BPH |
| US10335453B2 (en) | 2017-03-01 | 2019-07-02 | Nymox Corporation | Compositions and methods for improving sexual function |
| EP3666276A1 (en) | 2018-12-14 | 2020-06-17 | dcic Biopharmaceutical Limited | Medication against estrogen-receptor beta (erbeta) positive breast tumor |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3423507A (en) * | 1966-02-25 | 1969-01-21 | Schering Corp | Method of treating benign prostratic hypertrophy |
| US4055641A (en) * | 1976-05-10 | 1977-10-25 | Richardson-Merrell Inc. | Method of treating benign prostatic hypertrophy |
| DE2817157A1 (de) * | 1978-04-17 | 1979-10-25 | Schering Ag | Verwendung von antioestrogenen und antigonadotrop wirkenden antiandrogenen zur prophylaxe und therapie der prostatahyperplasie |
| US4235893A (en) * | 1978-05-08 | 1980-11-25 | Brodie Angela M | Ester derivatives of 4-hydroxy-4-androstene-3,17-dione and a method for inhibiting estrogen biosynthesis |
| EP0100566B1 (en) * | 1982-07-14 | 1986-02-19 | Akzo N.V. | Novel 19-thio-androstane derivatives |
-
1981
- 1981-05-22 DE DE19813121153 patent/DE3121153A1/de active Granted
- 1981-07-31 SE SE8104625A patent/SE462639B/sv not_active IP Right Cessation
- 1981-08-10 CH CH5142/81A patent/CH648485A5/de not_active IP Right Cessation
- 1981-08-10 DK DK354781A patent/DK354781A/da not_active Application Discontinuation
- 1981-08-11 LU LU83544A patent/LU83544A1/de unknown
- 1981-08-17 JP JP56127856A patent/JPS57193411A/ja active Granted
- 1981-08-19 NL NL8103874A patent/NL8103874A/nl not_active Application Discontinuation
- 1981-09-24 IT IT24117/81A patent/IT1168028B/it active
- 1981-09-28 BE BE0/206084A patent/BE890521A/fr not_active IP Right Cessation
-
1982
- 1982-05-10 GB GB08213404A patent/GB2100601B/en not_active Expired
- 1982-05-19 ZA ZA823500A patent/ZA823500B/xx unknown
- 1982-05-24 AU AU84074/82A patent/AU563524B2/en not_active Ceased
-
1985
- 1985-05-13 US US06/733,436 patent/US4596797A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CH648485A5 (de) | 1985-03-29 |
| DK354781A (da) | 1982-11-23 |
| JPS57193411A (en) | 1982-11-27 |
| US4596797A (en) | 1986-06-24 |
| GB2100601B (en) | 1986-02-05 |
| DE3121153C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1991-06-20 |
| DE3121153A1 (de) | 1982-12-09 |
| NL8103874A (nl) | 1982-12-16 |
| SE8104625L (sv) | 1982-11-23 |
| AU8407482A (en) | 1982-11-25 |
| IT8124117A0 (it) | 1981-09-24 |
| ZA823500B (en) | 1983-03-30 |
| BE890521A (fr) | 1982-03-29 |
| GB2100601A (en) | 1983-01-06 |
| LU83544A1 (de) | 1981-12-01 |
| AU563524B2 (en) | 1987-07-16 |
| SE462639B (sv) | 1990-08-06 |
| JPH0150206B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1989-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1168028B (it) | Impiego di inibitori dell'aromatasi per la profilassi e la terapia della iperplasia della prostata | |
| DE3851121D1 (de) | Filamentlose Magnetron-Ionenquelle und Verwendungsverfahren. | |
| FR2506158B1 (fr) | Medicament a base d'une association d'un inhibiteur de l'aromatase et d'un anti-androgene, utilisable pour le traitement et la prevention de l'hyperplasie de la prostate | |
| DK0526544T3 (da) | Terapeutiske anvendelser af actinbindende forbindelser | |
| NO893240L (no) | Anvendelse av alfa-aminoborsyrederivater til profylaktisk og behandling av virussykdommer. | |
| KR920700634A (ko) | 좌창 또는 건선 피부병을 치료하는 방법 및 여기에 사용되는 조성물 | |
| DE3650620D1 (de) | Behandlungsverfahren kataboler dysfunktion | |
| ATE69953T1 (de) | Verwendung von polysulfatierten heparinen. | |
| NO894222D0 (no) | Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder. | |
| DE3854121D1 (de) | Arzneimittelzusammensetzungen zur behandlung von psoriasis. | |
| ATE145825T1 (de) | Behandlung von erhöhtem blutdruck | |
| DK325289A (da) | Strontiumsalt, fremgangsmaade til fremstilling heraf samt farmaceutiske midler indeholdende saltet | |
| NO922136D0 (no) | Anvendelse av gibberelliner for behandling av prostatitisog psoriasis | |
| NO894008D0 (no) | Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme. | |
| EP0350738A3 (de) | (S)-Emopamil zur Anwendung bei der Behandlung von Migräne | |
| IT1219439B (it) | Procedimento ed apparecchio per il trattamento elettrochimico di pezzi | |
| FI844645A0 (fi) | 1,7-difenyl-3-metylaza-7-cyan-8 -metyl-nonan foer anvaendning vid bekaempning av sjukdomar. | |
| DE3574375D1 (de) | Isoxazole and isothiazole derivatives | |
| SE8501202D0 (sv) | Human intestinal hormone and its use | |
| NO864272D0 (no) | Fremgangsmaate og anordning for haandtering av boreroer. | |
| DE3879709D1 (de) | Platin-arzneimittel. | |
| IT8947610A0 (it) | Agente e procedimento per la concia del cuoio | |
| NO892506L (no) | Kloning og ekspresjon av human vevsfaktor. | |
| BE900654A (fr) | Composition pharmaceutique et procede de traitement de l'excitation. | |
| IT8648619A0 (it) | Preparati farmaceutici per il trattamento della vitiligine e della psoriasi |